share_log

HC Wainwright & Co. Maintains Buy on Affimed, Lowers Price Target to $5

HC Wainwright & Co. Maintains Buy on Affimed, Lowers Price Target to $5

HC Wainwright & Co.維持對Affimed的買入,將目標價下調至5美元
Benzinga ·  2023/06/05 09:53

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Affimed (NASDAQ:AFMD) with a Buy and lowers the price target from $6 to $5.

HC Wainwright & Co. 分析師Swayampakula Ramakanth維持Affimed(納斯達克股票代碼:AFMD)的買入,並將目標股價從6美元下調至5美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論